We believe our first responsibility is to the patients, doctors and nurses, to mothers and fathers and all others who use our products and services.
In meeting their needs everything we do must be of high quality.
We must constantly strive to provide value, reduce our costs and maintain reasonable prices..
1961.
Janssen Pharmaceutica was acquired by Johnson & Johnson, bringing to the company Janssen's strong capabilities in the growing field of pharmaceutical medicines..
We believe our first responsibility is to the patients, doctors and nurses, to mothers and fathers and all others who use our products and services.
In meeting their needs everything we do must be of high quality.
We must constantly strive to provide value, reduce our costs and maintain reasonable prices..
Zacharias Janssen is generally believed to be the first investigator to invent the compound microscope.
However, because the accomplishment is generally agreed among historians to be dated in the 1590s, most scholars believe that his father, Hans, must have played an important role in the creation of the instrument..
Janssen has grown from a small business in Belgium to one of the world's top ten pharmaceutical companies. [1] Its namesake, Dr Paul Janssen, lay the groundwork for over 80 medicines that have gone on to save millions of lives..
As a leading pharmaceutical company in the United States, we focus our innovation on some of the most devastating diseases and the most complex medical challenges of our time, across six therapeutic areas: Cardiovascular & Metabolism.
Immunology.
Infectious Diseases & Vaccines..
NEW YORK – Janssen on Wednesday said it will pay Cellular Biomedicine Group (CBMG) $245 million upfront in a licensing and collaboration deal focused on developing, manufacturing, and commercializing CAR T-cell therapies for B-cell malignancies.May 3, 2023.
Janssen aims to change the way diseases are treated, and aggressively pursues new pathways, investigating new technologies and treatment modalities in Oncology, Immunology, Neuroscience, Infectious Diseases & Vaccines, Cardiovascular, Metabolism & Retina, and Pulmonary Hypertension..
1961.
Janssen Pharmaceutica was acquired by Johnson & Johnson, bringing to the company Janssen's strong capabilities in the growing field of pharmaceutical medicines.
For Dr Paul Janssen, the global reach of Johnson & Johnson would enable him and his colleagues to help more patients..
The Janssen story starts in 1953, in the Belgium town of Beerse.
It was here a young medical doctor called Dr Paul Janssen established the research laboratory, Janssen Pharmaceutica.
Success came quickly..
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson..
Janssen has an established portfolio of biologics, including:
Janssen Biotech, Inc., a member of the Johnson & Johnson Family of Companies, is recruiting for an Immunology Sales Specialist, Dermatology to support the New Orleans-Baton Rouge, LA territory.
At ..
More Info.
“We are committed to advancing the science and treatment of B-cell malignancies, especially in DLBCL where deeper responses and long-term remissions represent a persistent unmet need,” said Sen Zhuang, M.D., Ph.D., Vice President, Clinical Research and Development, Janssen Research & Development, LLC.
Together with Legend Biotech, Janssen is developing a CAR-T cell therapy in MM.
Janssen views this single asset collaboration as a foundational component of potential future integrated solutions within its larger hematologic malignancy program.
The CAR-T cell therapy is undergoing regulatory reviews in multiple countries. • B cell malignancies.
